David Holbrook

Dr David Holbrook is a leading healthcare investment technology professional with 30 years’ experience in the life sciences sectors. He has sat on more than 20 boards of directors during his career. He is currently a non-executive director at Oxford BioDynamics plc and a senior adviser to RYSE Asset Management. Trained as a physician, David has also held senior business development roles at Glaxo, Roche and in biotech, and has an MBA from Harvard.